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Summary
Dyspnoea, a much less specific symptom of ischaemia than chest discomfort, is
common among obese patients. Patients with dyspnoea often undergo stress
testing as part of their evaluation. We sought to examine the yield of stress testing
in non-elderly, obese, sedentary patients with dyspnoea on exertion (DOE) as a
chief complaint.We reviewed stress echocardiograms carried out on 203 patients
in a stress testing laboratory at a major tertiary care centre. Of these, 81 (40%) fell
into a group that was at low risk for coronary artery disease (CAD) by clinical
criteria. Ischaemia was detected in two patients in the low-risk group (2.5%), and
these results were likely false positives. In the higher risk group, 9.0% of func-
tional tests showed ischaemia; after further testing, 2.5% of the higher risk
patients were found to have obstructive coronary lesions. Clinical follow-up was
performed for a mean of 815 days. New obstructive coronary disease was detected
in 1.6% of all patients, and these patients were from the higher risk group. In
obese sedentary patients with DOE but otherwise at low risk of coronary disease
stress testing is of very low yield. DOE is generally not an anginal equivalent in
this patient population.
Keywords: Coronary artery disease, dyspnoea on exertion, stress
echocardiography.
Introduction
Dyspnoea on exertion (DOE) is a non-specific symptom (1).
In some cases dyspnoea seems to represent an anginal
equivalent (2–5), and in patients at elevated risk for CAD,
dyspnoea may predict higher rates of cardiac death and
non-fatal myocardial infarction (6–13), although not all
studies confirm this finding (14), and worse outcomes may
not be linked to a greater burden of ischaemia (15,16).
Concern about DOE as an anginal equivalent is often
extended to patients who are not at high risk for coronary
artery disease (CAD) by clinical criteria, and limited data
suggest that such patients may not in fact have an increased
prevalence of CAD (17). There is little guidance from the
literature regarding stress testing in patients at low risk for
CAD who have DOE. The most recent American College of
Cardiology/AmericanHeart AssociationGuideline for Exer-
cise Testing does not discuss pre-test probability of dyspnoea
as a symptom of CAD (18). The 2009 Appropriate Use
Criteria for Cardiac Radionuclide Imaging acknowledges
that dyspnoea can be an anginal equivalent, but no specific
recommendations regarding testing are given (19). In a
population with a low prevalence of the condition for which
testing is being performed, most positive tests will be false
positives (20,21). This results in further testing, with
increased expense to society and increased risk to patients.
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We determined the prevalence of CAD in a group of
patients with DOE but otherwise at low risk for CAD. We
chose to evaluate a group with alternative explanations for
DOE. We reviewed stress tests and performed chart review
on non-elderly, obese, sedentary patients for whom the
stress test indication was dyspnoea. We identified patients
in this group who were at low risk for CAD using usual
clinical criteria. Patients at increased risk were evaluated in
parallel. Outcomes suggesting CAD as a cause of DOE
included ischaemia on stress testing, CAD by catheteriza-
tion and coronary events occurring during follow-up. The
hypothesis was that DOE is not generally an anginal
equivalent in clinically low-risk groups, particularly if there
is an alternative explanation for DOE, and that testing for
CAD as the cause of DOE (specifically with stress
echocardiograms) is not helpful in evaluating DOE in this
population.
Methods
Population
The University of Michigan maintains a computer database
of all echocardiographic stress tests that includes body
mass index (BMI), activity level (with ‘sedentary’ as one
category) and indication for the test. This database was
queried to identify all patients younger than age 55, with
BMI greater than 30, and listed as having a sedentary
lifestyle as assessed by the exercise physiologist, for whom
the test indication was dyspnoea. Patients were judged to
be sedentary if they did not have any regular significant
level of physical activity [e.g normal levels of activity less
than about four metabolic equivalents (METs)] either at
work or at home. A cross-sectional (for initial follow-up
testing) and retrospective cohort (for longitudinal follow-
up) design was utilized. Tests performed from October
2007 to January 2011 were evaluated.
Baseline risk factors
Records were reviewed to clarify the character of the
patient’s presenting symptoms (presence or absence of
chest pain and its character, dyspnoea and symptom sever-
ity). Patients for whom DOE was the chief complaint, as
assessed by chart review, were included in the study.
Patients with chest discomfort suggestive of angina were
assigned to the higher risk group. The medical history was
evaluated for indicators of increased risk, including coro-
nary disease (with or without previous revascularization),
diabetes mellitus (and whether there was a requirement for
insulin), hypertension (and/or requirement for anti-
hypertensive medication), cerebrovascular disease, past or
active smoking, and family history of premature CAD
(first-degree relatives with coronary disease before 55 in
men or before 65 in women). Patients with any of
these findings were assigned to the higher risk group. The
physical examination was evaluated for abnormalities,
principally cardiac murmurs and rales. The resting electro-
cardiogram (ECG) was evaluated for abnormalities sugges-
tive of ischaemia or other significant pathology; specifically,
Q waves, abnormal T-wave inversion, right or left ventricu-
lar hypertrophy (LVH), tachycardia of any type including
sinus tachycardia (22), premature ventricular contractions,
atrial fibrillation, atrioventricular block of any degree,
bundle branch block or intraventricular conduction delay.
Baseline risk factors were used to calculate Framingham
10-year risk scores (23). Patients with any of these abnor-
malities on physical examination or ECG, or who had a
10-year risk of 10% or more of adverse cardiac events by
Framingham scoring, were assigned to the higher risk
group. (Patient characteristics are shown in Table 1.)
Stress testing
Exercise and dobutamine stress echocardiograms were con-
ducted according to standardized procedures utilized
throughout the health system. Standard exercise stress
protocols were used (24). The adequacy of the exercise tests
was judged according to the level of cardiac stress (a
pressure–rate product of >250 mmHg × beats min−1) and
the exercise tolerance (average or greater, determined by
number of METS on an age-based nomogram).
Table 1 Patient characteristics
Risk factors and clinical presentation n or mean % or IQR*
Male 101 49.8%
Age 46.2 43–51
BMI 37.6 33.0–39.8
History of CAD 14 6.9%
Cerebrovascular disease 1 0.5%
Diabetes
All 41 20.2%
On insulin 18 8.9%
Family history 31 15.3%
Smoking history
All 76 37.4%
Current smoking 33 16.3%
Hypertension 111 54.7%
Dyslipidaemia 140 69.0%
Framingham score 3.6 1–5
Typical angina 9 4.4%
Abnormal resting ECG 57 28.1%
Q wave 22 10.8%
T-wave inversion 24 11.8%
ST-segment depression 1 0.5%
LV hypertrophy 12 5.9%
*Interquartile range (25–75%ile).
BMI, body mass index; CAD, coronary artery disease; ECG,
electrocardiogram; LV, left ventricular.
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Dobutamine stress tests were deemed adequate if the
patient’s maximum heart rate recorded was >85% of the
age-predicted maximum heart rate (calculated as 220 –
[patient’s age]).
Echocardiography
Echocardiographic information was reviewed. The primary
finding for which the tests were evaluated was the presence
of new or worsening regional wall motion abnormality
with stress. Fixed wall motion abnormalities consistent
with regions of previous infarction were also noted. The
resting echocardiogram was evaluated for alternative
explanations for dyspnoea, including severe pulmonary
hypertension, moderate or severe valvular stenosis or regur-
gitation, evidence of cardiomyopathy [ejection fraction
(EF) 40% or less], diastolic dysfunction (and its grade) and
more than mild right heart dilation.
Follow-up testing
Charts were reviewed for follow-up testing, particularly
cardiac catheterizations and nuclear perfusion scans. Test
results were examined for evidence of new obstructive
coronary lesions judged likely to be responsible for symp-
toms. Charts were also reviewed for assessment by the
ordering clinician whether a clinically significant cause of
the dyspnoea was found. The records were examined lon-
gitudinally to determine whether any patients experienced
subsequent cardiovascular events in the post-testing period.
Episodes of heart failure, myocardial infarction,
revascularization or cardiac surgery were noted. All
patients, including those with inadequate stress tests, were
followed.
Statistical analysis
Continuous variables were reported as mean with 95%
confidence interval (CI). Comparisons between means were
performed according to the Student’s t-test. Categorical
variables were compared according to the chi-squared test
(or Fisher’s exact test for categorical variables with less
than five observations). Analysis of time to event data was
performed using a univariate Cox model. Because of the
low event rate, Cox models beyond one predictor could not
be created. Statistical significance from the Cox models
were assessed using the likelihood ratio test (favoured for
small sample sizes). Hazard ratios could not be estimated
from the model due to no observed events in the low-risk
group. Statistical significance was determined at the
P < 0.05 level. Statistical analysis was performed on the
JMP Platform (version 10; SAS Institute, Cary, NC, USA)
for descriptive analyses and SAS 9.3 ×64 Platform for Cox
model.
Results
There were 244 patients identified by the echocardiography
database who met the initial inclusion criteria of age less
than 55, BMI greater than 30 and sedentary lifestyle. Of
these, 203 (83.2%) patients were eligible for inclusion into
the final data analysis and 41 (16.8%) were excluded
(Fig. 1). The primary reasons for exclusion were missing
data (in 20 patients), referral from outside the health
system so that progress notes and records were not avail-
able for review (11 patients), and testing performed for
known disease, including pulmonary hypertension, hyper-
trophic cardiomyopathy (HCM) and ischaemic cardiomyo-
pathy (nine patients). Among the 203 included patients, the
most frequent referring specialties were general internal
medicine (105 patients, 51.7%), family medicine (39
patients, 19.2%) and cardiology (32 patients, 15.8%), as
shown in Fig. 2. There were a smaller proportion of
patients referred from medical subspecialty clinics and
from surgery/anaesthesiology. One patient was referred
from the emergency department.
Patient risk factors
Patients were assessed for factors that would affect pre-test
probability for CAD (see Baseline Risk Factors in Methods
section above). Patients with none of these factors were
taken to be the low-risk group. A total of 81 patients
(39.9% of the total sample) were assigned to the low-risk
group.
Testing modalities
The stress modality was treadmill exercise echo in 156
patients (76.8%) and dobutamine echo in 47 patients
(23.2%). Stress tests were inadequate to assess for ischae-
mia in a total of 47 patients, either because of inadequate
workload attained or because of inadequate images. Sev-
enteen patients in the treadmill group failed to reach
adequate stress thresholds. Twenty patients in the
dobutamine group failed to reach target heart rate. There
were 12 patients with poor quality echocardiogram images.
Two of these 12 patients also had inadequate workload
achieved on stress testing. There was no difference in
adequacy of imaging between the low-risk and high-risk
groups. In the higher risk group, 27.1% of tests were
inadequate and 17.3% were inadequate in the low-risk
group (odds ratio 1.77; 95% CI 0.88–3.6; P = 0.13
by Fisher’s exact test). Follow-up non-invasive testing
was performed in 10 patients due to inadequate
echocardiographic stress tests.
Initial test results
In total, there were 13 (6.4%) studies with findings con-
sistent with inducible ischaemia. In the low-risk group, two
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patients (2.47%) had positive studies, compared with 11
patients (9.02%) in the higher risk group. There was no
statistically significant difference in the rate of test positiv-
ity between the low- and high-risk groups (P = 0.08 by
Fisher’s exact test). The overall rate of test positivity was
not different between testing modalities (dobutamine vs.
exercise).
Confirmatory testing
Immediate follow-up testing (with nuclear perfusion scan
or cardiac catheterization) was performed in 11 (84.6%) of
the 13 patients with inducible ischaemia. Of the two
patients in the low-risk group with positive studies, con-
firmatory testing was negative in one and was never per-
n = 244 sampled from database n = 41 (16.8%) excluded
-n = 20 (8.2%) with missing data
-n = 11 (4.5%) referrals
-n = 9 (3.7%) specific indication
-n = 7 (2.9%) pulmonary HTN
-n = 1 (0.4%) HOCM
-n = 1 (2.4%) viability study
-n = 1 (0.4%) database error
n = 203 (83.2%) included 
n = 156 (76.8%) treadmill
n = 47 (23.2%) dobutamine
Low-risk group
n = 81 (39.9%)
Positive stress echocardiogram
n = 2/81 (2.5%)
Inadequate study
n = 14/81(17.3%)
Positive confirmatory testing
n = 0/81 (0%)
CAD event during follow-up
n = 0/79 (0%)
Total newly diagnosed CAD
(low risk)
n = 0/81 (0%)
Higher risk group
n = 122 (60.1%)
Positive stress echocardiogram
n = 11/122 (9.0%)
Inadequate study
n = 33/122 (27.1%)
Positive confirmatory testing
n = 3/122 (2.5%)
CAD event during follow-up
n = 4/113 (3.5%)
Total newly diagnosed CAD
(high risk)
n = 7/122 (5.7%)
P = 0.028*
P = 0.3
P = 0.13
P = 0.08
P = 0.04*
Figure 1 Diagnostic algorithm. CAD,
coronary artery disease; HOCM,
hypertrophic obstructive cardiomyopathy;
HTN, hypertension.
Figure 2 Referring specialties. Pareto chart
of referring specialties, showing bar graph of
counts and line of cumulative percentage.
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formed in the other, because her symptoms resolved prior
to follow-up and never recurred. Hence, no members of the
low-risk group were found to have obstructive CAD. In the
higher risk group, three patients (2.46%) were ultimately
diagnosed with new obstructive coronary lesions by cardiac
catheterization. This difference was not statistically signifi-
cant (P = 0.3 by Fisher’s exact test).
Although not every patient received confirmatory testing
(in this case, nuclear perfusion scanning or diagnostic angi-
ography), the sensitivity, specificity and predictive values of
stress echocardiography can be estimated. For all subjects,
the estimated sensitivity is 66.7% (95% CI 20.8–93.9%),
specificity 94.5% (95% CI 90.4–96.9%). Given the low
disease prevalence of 1.5%, the positive predictive value in
this population is very low at 15.4% (95% CI 4.3–42.2%).
Alternative diagnoses
The symptoms of 89 patients were ascribed to diagnoses
other than CAD during subsequent follow-up (Fig. 3). The
alternative diagnoses were frequently pulmonary (in
40 patients), and included asthma or bronchospasm (29
patients), chronic obstructive pulmonary disease (three
patients), interstitial lung disease (five patients), pulmonary
arteriovenous malformation (one patient) and diaphrag-
matic paralysis (one patient). Alternative cardiac diagnoses
were found in 24 patients, and included diastolic congestive
heart failure (diastolic CHF) in six patients, valvular
disease in three patients and non-ischaemic cardio-
myopathy in three patients. Deconditioning was directly
implicated by the referring physician in 19 patients.
Symptoms were ultimately attributed to anxiety in five
patients.
In some cases the echocardiographic results suggested
alternative diagnoses that might account for symptoms.
Ejection fraction was <40% in three patients. Severe mitral
regurgitation was identified in two patients. No patients
had right ventricular (RV) systolic pressure >40 mmHg.
There was evidence of RV dysfunction in three patients; RV
dysfunction was mild in two of these and mild to moderate
in the third. Diastolic dysfunction of grade 2 or greater
in severity was present in six patients. LVH was present in
54 patients, but severe LVH was present in only one
patient, and that person was subsequently diagnosed with
HCM.
Follow-up testing
The 200 patients (98.5%) without obstructive lesions iden-
tified on initial evaluation were followed for subsequent
development of new obstructive coronary lesions of >70%
stenosis by coronary angiography. There were eight patients
excluded for lack of follow-up information, for a total of
192 patients with follow-up information available. There
was a broad range of follow-up intervals. The median
follow-up was 815 days, with a 25–75% interquartile range
of 548–1083 days.
In total, there were three (1.56%) patients who devel-
oped objectively documented obstructive coronary disease
during the follow-up interval. An additional patient had an
episode of coronary vasospasm resulting in ST elevation.
All of these patients were members of the higher risk group.
The difference in rate of detection of obstructive coronary
disease between the low and higher risk groups during the
follow-up period was statistically significant (P = 0.028 by
likelihood ratio test), with the lower 95% bound of the
hazard ratio of 1.4.
Diaphragmatic paralysis
GERD
HCM
PAH
Pulmonary AVM
Malignancy
COPD
NICM
Valvular
Anxiety
ILD
Diastolic CHF
Arrhythmia
Deconditioning
Bronchospasm/asthma
1%
1%
1%
1%
1%
2%
3%
3%
3%
6%
6%
7%
10%
21%
33%
5 10 15 20 25 30
Number of patients
Figure 3 Alternative diagnoses. Bars are
labelled with percentage of total. AVM,
arteriovenous malformation; CHF, congestive
heart failure; COPD, chronic obstructive
pulmonary disease; GERD,
gastro-oesophageal reflux disease; HCM,
hypertrophic cardiomyopathy; ILD, interstitial
lung disease; NICM, non-ischaemic
cardiomyopathy; PAH, pulmonary arterial
hypertension.
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The overall difference in diagnosis of obstructive coro-
nary disease between the low and higher risk groups includ-
ing initial testing was also statistically significant (P = 0.04
by Fisher’s exact test).
Comment
This study represents the first analysis of the performance
of stress echocardiography in non-elderly, obese, sedentary
patients who present with DOE as their sole symptom. A
prior study also found stress echo to be of very low yield
in low-risk groups, but that study did not assess dyspnoeic
patients (25). While patients in the current study were by
most standard criteria at low risk for CAD, they had
symptoms that are often thought to represent an anginal
equivalent. Review of stress echocardiograms performed
on the low-risk group reveals a very low rate of apparent
ischaemia, and the two tests suggesting ischaemia were in
fact most likely false-positive results. No obstructive CAD
was found in this group. Event rates in this group were
also very low, with no myocardial infarctions occurring
during extended follow-up. It is noteworthy that, in the
group of patients with markers of higher risk that we
evaluated in parallel, the few new obstructive coronary
lesions that were detected occurred in patients presenting
with typical angina. These findings support guideline rec-
ommendations stating that the strongest indication for
stress testing and the most specific symptom of ischaemia
is chest pain, especially typical angina. Our findings
suggest that DOE is not generally an anginal equivalent in
patients similar to those studied here, particularly the
lower risk group, and that evaluation for CAD with stress
echocardiograms is not helpful in patients like those pre-
sented here who are at low risk for CAD by usual clinical
criteria. It is worth noting in this context that there are
data suggesting that obesity actually protects against
adverse cardiovascular outcomes (the so-called obesity
paradox) (26), and this may help explain the very low
rates of ischaemia and acute coronary syndromes detected
in our study.
Our data do support alternative testing and management
strategies for this population. A much less expensive and
potentially higher yield test for aetiologies of dyspnoea,
especially in patients at low risk for CAD, is cardiopulmo-
nary exercise testing (CPET), which can be used to assess
for pulmonary and cardiac conditions of various types with
a single test (27). The high incidence of pulmonary causes
of dyspnoea in our low-risk test population suggests that it
would have been reasonable to send these patients for
CPET or other pulmonary evaluation instead of or prior to
standard imaging stress tests. Several patients in the low-
risk group also had cardiac abnormalities detected by
echocardiogram that might be responsible for dyspnoea,
suggesting that resting echocardiographic data might have
been helpful in this group. Another reasonable manage-
ment strategy might be a supervised weight loss and exer-
cise programme with further evaluation dependent on
whether symptoms are persistent.
Our evaluation has limitations. This was a single-centre
study, and so our findings might not be generally applicable
to other institutions, although it is not immediately appar-
ent why this would be true. Our sample size was limited
and thus lacked some degree of statistical power. Addition-
ally, the retrospective design could potentially introduce
reporting bias. However, a large proportion of the patients
had longitudinal follow-up with their primary care physi-
cians within the health system and data were collected
prospectively at the time of clinic visits. As expected with
stress testing, particularly when testing a group of obese
patients, there was a fairly high rate of inadequate stress
tests. This may result in underestimation of CAD in the
study. However, all of these patients had extended clinical
follow-up to determine the subsequent rate of clinical coro-
nary events and to determine the diagnoses that were ulti-
mately felt to explain their symptoms. This adds significant
additional information regarding the likely prevalence of
CAD in this group.
The work presented here may contribute to safe limita-
tion of stress testing. One way this might be accomplished
is by development of a clinical scoring system that would
predict risk of CAD in patients with dyspnoea but no chest
pain. Scoring systems using specific risk markers have been
successfully applied to reduce testing in other medical con-
ditions. One example is the PERC scoring system that is
used to risk stratify patients with possible pulmonary
embolus (28). A low PERC score defines a group at such
low risk of pulmonary embolus that no further testing is
recommended or desirable. An analogous scoring system
for patients with dyspnoea would be extremely useful, and
could serve to limit, in a safe manner, the number of stress
tests performed in this group.
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